BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31482667)

  • 1. The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication.
    Harris S; Cirino AL; Carr CW; Tafessu HM; Parmar S; Greenberg JO; Szent-Gyorgyi LE; Ghazinouri R; Glowny MG; McNeil K; Kaynor EF; Neumann C; Seidman CE; MacRae CA; Ho CY; Lakdawala NK
    Mol Genet Genomic Med; 2019 Nov; 7(11):e940. PubMed ID: 31482667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated with Uptake of Genetics Services for Hypertrophic Cardiomyopathy.
    Khouzam A; Kwan A; Baxter S; Bernstein JA
    J Genet Couns; 2015 Oct; 24(5):797-809. PubMed ID: 25566741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives.
    Norrish G; Jager J; Field E; Quinn E; Fell H; Lord E; Cicerchia MN; Ochoa JP; Cervi E; Elliott PM; Kaski JP
    Circulation; 2019 Jul; 140(3):184-192. PubMed ID: 31006259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family screening in hypertrophic cardiomyopathy is underperformed, but can be improved by a specialised clinic.
    Olaussen A; Beale A; Macciocca I; Ellims AH
    Intern Med J; 2014 Jul; 44(7):665-70. PubMed ID: 24766218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup.
    Ko C; Arscott P; Concannon M; Saberi S; Day SM; Yashar BM; Helms AS
    Genet Med; 2018 Jan; 20(1):69-75. PubMed ID: 28640247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.
    Arad M; Monserrat L; Haron-Khun S; Seidman JG; Seidman CE; Arbustini E; Glikson M; Freimark D
    Isr Med Assoc J; 2014 Nov; 16(11):707-13. PubMed ID: 25558701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients With Hypertrophic Cardiomyopathy and Normal Genetic Investigations Have Few Affected Relatives.
    Nielsen SK; Hansen FG; Rasmussen TB; Fischer T; Lassen JF; Madsen T; Møller DS; Klausen IC; Brodersen JB; Jensen MSK; Mogensen J
    J Am Coll Cardiol; 2023 Oct; 82(18):1751-1761. PubMed ID: 37879779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing and cascade screening in pediatric long QT syndrome and hypertrophic cardiomyopathy.
    Knight LM; Miller E; Kovach J; Arscott P; von Alvensleben JC; Bradley D; Valdes SO; Ware SM; Meyers L; Travers CD; Campbell RM; Etheridge SP
    Heart Rhythm; 2020 Jan; 17(1):106-112. PubMed ID: 31229680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.
    van Velzen HG; Schinkel AFL; Baart SJ; Oldenburg RA; Frohn-Mulder IME; van Slegtenhorst MA; Michels M
    Circ Genom Precis Med; 2018 Apr; 11(4):e001896. PubMed ID: 29661763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy-A systematic review and meta-analysis.
    Cirino AL; Harris SL; Murad AM; Hansen B; Malinowski J; Natoli JL; Kelly MA; Christian S
    J Genet Couns; 2022 Dec; 31(6):1290-1305. PubMed ID: 35799446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
    Lafreniere-Roula M; Bolkier Y; Zahavich L; Mathew J; George K; Wilson J; Stephenson EA; Benson LN; Manlhiot C; Mital S
    Eur Heart J; 2019 Dec; 40(45):3672-3681. PubMed ID: 31170284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing.
    Jensen MK; Havndrup O; Christiansen M; Andersen PS; Diness B; Axelsson A; Skovby F; Køber L; Bundgaard H
    Circulation; 2013 Jan; 127(1):48-54. PubMed ID: 23197161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living with hypertrophic cardiomyopathy.
    Subasic K
    J Nurs Scholarsh; 2013 Dec; 45(4):371-9. PubMed ID: 23815576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating a communication aid for return of genetic results in families with hypertrophic cardiomyopathy: A randomized controlled trial.
    Burns C; Yeates L; Sweeting J; Semsarian C; Ingles J
    J Genet Couns; 2023 Apr; 32(2):425-434. PubMed ID: 36385718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY).
    Mirabel M; Damy T; Donal E; Huttin O; Labombarda F; Eicher JC; Cervino C; Laurito M; Offredo L; Tafflet M; Jouven X; Giura G; Desnos M; Jeunemaître X; Empana JP; Charron P; Habib G; Réant P; Hagège A;
    Int J Cardiol; 2019 Jan; 275():107-113. PubMed ID: 30316646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Testing for Diagnosis of Hypertrophic Cardiomyopathy Mimics: Yield and Clinical Significance.
    Hoss S; Habib M; Silver J; Care M; Chan RH; Hanneman K; Morel CF; Iwanochko RM; Gollob MH; Rakowski H; Adler A
    Circ Genom Precis Med; 2020 Apr; 13(2):e002748. PubMed ID: 32150461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation.
    van Velzen HG; Schinkel AFL; Oldenburg RA; van Slegtenhorst MA; Frohn-Mulder IME; van der Velden J; Michels M
    Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28794111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empowering Family Glaucoma Risk Communication Using QR-Code-Mediated Online Intervention.
    Hallaj S; Shah SJ; Cehelyk EK; Hock LE; Lee D; Razeghinejad R; Myers JS; Frasso R; Kolomeyer NN
    Ophthalmol Glaucoma; 2024; 7(2):190-196. PubMed ID: 37838087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.